Last updated on NOVEMBER 16, 2011
Applies to:Oracle Argus Safety - Version: 220.127.116.11
Information in this document applies to any platform.
The FDA has issued new regulations that support a more specific causality assessment in clinical trials.
The respective causality assessments are FDA specific and need to be kept apart from the causality assessment for other regulators, such as the EMA or European CAs.
The rule becomes effective September 1, 2011.
Argus needs to provide a 3rd causality field at the level of the as reported / determined causality.
Can you please explain how we can do this in Argus Safety.
Sign In with your My Oracle Support account
Don't have a My Oracle Support account? Click to get started
Million Knowledge Articles and hundreds of Community platforms